SCHEMBL17636686

SCHEMBL17636686

c1ccc(-c2nc(-c3cccc4c3c3ccccc3n4-c3cccc(-n4c5ccccc5c5ccccc54)c3)nn2-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 2/20 0.43
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM6B O15054 1/20 0.36
ABCC4 O15439 1/20 0.36
ABCB11 O95342 1/20 0.36
KDM5A P29375 1/20 0.36
BLVRB P30043 1/20 0.36
SCN5A Q14524 1/20 0.36
KCND3 Q9UK17 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17636674 0.91 KDM4A (0.43) KDM4AKDM4EATML3MBTL1KDM6B
SCHEMBL17636633 0.91 KDM4A (0.45) KDM4AKDM4EATML3MBTL1SMN1; SMN2
SCHEMBL17636697 0.88 ALDH1A1 (0.40) KDM4AKDM4EATMMEN1KMT2A
SCHEMBL17636689 0.86 MAPT (0.41) KDM4EL3MBTL1SMN1; SMN2KMT2AALDH1A1
SCHEMBL17636645 0.84 KDM4E (0.41) KDM4AKDM4EATML3MBTL1SMN1; SMN2
SCHEMBL21532484 0.84 KDM4A (0.38) KDM4AKDM4EATML3MBTL1KDM6B
SCHEMBL17636683 0.84 KDM4E (0.39) KDM4EATML3MBTL1SMN1; SMN2MEN1
SCHEMBL17636624 0.83 KDM4A (0.45) KDM4AKDM4EATML3MBTL1KDM6B
SCHEMBL17636642 0.83 KDM4E (0.41) KDM4AKDM4EATML3MBTL1SMN1; SMN2
SCHEMBL17636662 0.83 KDM4E (0.41) KDM4AKDM4EATML3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 KDM4A 1981/4885KDM4E 2877/4885ATM 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.